Yamato Keidai

11PUBLICATIONS
18CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Microelectromechanical systems (MEMS)Epidemiological modellingPlant pathology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Apr 13, 2026
Estimated Glomerular Filtration Rate Change and Heart Failure Events With GLP-1 Receptor Agonists: A Meta-Analysis and Meta-Regression of Randomised Controlled Trials.

Masashi Hasebe, Hisashi Kamido, Chen-Yang Su

|Sep 10, 2025
Cardiovascular risk reduction with glucagon-like peptide-1 receptor agonists is proportional to HbA1c lowering in type 2 diabetes: An updated meta-regression analysis incorporating FLOW and SOUL trials.

Masashi Hasebe, Chen-Yang Su, Yamato Keidai

|Jun 19, 2025
Application of human iPSC-derived white, beige, and brown adipocytes for metabolic disease modeling and transplantation therapy.

Yamato Keidai, Junji Fujikura, Daisuke Yabe

|Jan 19, 2024
Human RFX6 regulates endoderm patterning at the primitive gut tube stage.

Toshihiro Nakamura, Junji Fujikura, Ryo Ito

|May 22, 2023
Stabilization of kidney function and reduction in heart failure events with sodium-glucose co-transporter 2 inhibitors: A meta-analysis and meta-regression analysis.

Yamato Keidai, Satoshi Yoshiji, Masashi Hasebe

|Jun 23, 2022
A unique profile of insulin antibody titer in islet-transplanted patients.

Yamato Keidai, Junji Fujikura, Toshihiro Nakamura

Pageof 2

Frequent Collaborators

4 joint publications

Satoshi Yoshiji

4 joint publications

Daisuke Yabe

4 joint publications

Masashi Hasebe

3 joint publications

Yorihiro Iwasaki